|
|
|
|
LEADER |
01018cam a22002533a 4500 |
003 |
GR-PaULI |
005 |
20201109102107.0 |
008 |
080122s1998 f eng |
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 616_994000000000000_CAN
|7 0
|9 14333
|a LISA
|b LISA
|c BSC
|d 2016-04-24
|l 0
|o 616.994 CAN
|p 026000328760
|r 2016-04-24 00:00:00
|w 2016-04-24
|y BK15
|
999 |
|
|
|c 7467
|d 7467
|
020 |
|
|
|a 0879695293
|
040 |
|
|
|a GR-PaULI
|b gre
|c GR-PaULI
|d GR-AiPI
|e AACR2
|
041 |
0 |
|
|a eng
|
082 |
1 |
4 |
|a 616.994
|2 23
|
245 |
1 |
0 |
|a Bladder cancer /
|c guest editors R.T.D. Oliver, M. J. Coptcoat.
|
260 |
|
|
|a New York :
|b Cold Spring Harbor Laboratory Press,
|c 1998.
|
300 |
|
|
|a vi, 170 σ. ;
|b εικ., πιν. ;
|c 26 εκ.
|
490 |
0 |
|
|a Cancer surveys
|v v. 31
|x 0261-2429
|
650 |
|
4 |
|a Ουροδόχος κύστη
|9 55544
|x Καρκίνος
|
700 |
1 |
|
|a Oliver, R.T.D.
|9 15968
|e επιμελητής.
|
700 |
1 |
|
|a Coptcoat, M.J.
|9 15969
|e επιμελητής.
|
710 |
2 |
|
|a Imperial Cancer Research Fund
|9 11028
|
942 |
|
|
|2 ddc
|c AV
|
998 |
|
|
|c ΒΕΛΛΙΟΥ
|d 2020-11
|